Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
LOXO-783
i
Other names:
LOXO 783, LOXO783, LOXO-783, LOX-22783, LY3849524
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Eli Lilly
Drug class:
PI3Kα H1047R mutation inhibitor
Related drugs:
‹
OKI-219 (5)
STX-478 (2)
OKI-219 (5)
STX-478 (2)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
HR positive + PIK3CA H1047R + PIK3CA D350G + ER D538G
HER2 Negative Breast Cancer
HR positive + PIK3CA H1047R + PIK3CA D350G + ER D538G
HER2 Negative Breast Cancer
LOXO-783
Sensitive: D – Preclinical
LOXO-783
Sensitive
:
D
LOXO-783
Sensitive: D – Preclinical
LOXO-783
Sensitive
:
D
HR positive + PIK3CA H1047R + ER D538G
HER2 Negative Breast Cancer
HR positive + PIK3CA H1047R + ER D538G
HER2 Negative Breast Cancer
LOXO-783
Sensitive: D – Preclinical
LOXO-783
Sensitive
:
D
LOXO-783
Sensitive: D – Preclinical
LOXO-783
Sensitive
:
D
HR positive + PIK3CA H1047R
HER2 Negative Breast Cancer
HR positive + PIK3CA H1047R
HER2 Negative Breast Cancer
LOXO-783
Sensitive: D – Preclinical
LOXO-783
Sensitive
:
D
LOXO-783
Sensitive: D – Preclinical
LOXO-783
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login